Swan Capital’s HealthEquity HQY Stock Holding History

Swan Capital’s Portfolio HQY Stock Details HQY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-6	Closed	-$629	–	516
2025 Q2	$629	Buy	+6	New	+$569	﹤0.01%	404

Other funds holding HQY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Swan Capital's HQY Position: Q3 2025 in Review

Swan Capital sold out of HealthEquity (HQY) in Q3 2025, closing a stake of 6 shares — an estimated $629 sold.

Swan Capital first reported a position in HQY in Q2 2025 and held it in 1 quarter. The position peaked at $629 in Q2 2025. 493 funds tracked by Wall St. Rank hold HQY as of Q3 2025.

Swan Capital reported no remaining HealthEquity position as of Q3 2025 after selling out during the quarter.
Swan Capital sold 6 HealthEquity shares in Q3 2025, an estimated $629.
Swan Capital first reported a position in HealthEquity in Q2 2025 and held it in 1 quarter.
Swan Capital's HealthEquity position peaked at $629 in Q2 2025.
493 funds tracked by Wall St. Rank held HealthEquity as of Q3 2025.

Based on Swan Capital's 13F filing for Q3 2025, filed 14 Nov 2025.